Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,236 across all filing types
Latest filing 2023-09-07 Director's Dealing
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
112年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, independent directors, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but the actual disclosure of insider shareholdings and transactions. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-09-07 Chinese
112年08月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related information. It is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. There is no indication that this is an announcement of a report or a certification, so it is not Regulatory Filings or Report Publication Announcement. The document length is about 5796 characters, which is sufficient for a detailed insider shareholding report. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-09-07 Chinese
112年08月法人說明會簡報 — 178920230822E001.pdf
Investor Presentation Classification · 95% confidence The document is titled 'ScinoPharm Investor Conference 2023 08 22' and contains detailed business updates, financial performance data including consolidated income statement and balance sheet for the first half of 2023, and operational progress. It includes forward-looking statements, business segment updates, product approval plans, and sales distribution by business, indication, and region. The content is structured as a presentation with slides and detailed financial and operational information aimed at investors. There is no indication that this is a transcript of a call, a regulatory filing, or a simple announcement. The document is a detailed presentation focusing on financials, strategy, and market position, consistent with an Investor Presentation (IP).
2023-08-22 Chinese
112年08月法人說明會簡報 — 178920230822M001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation from ScinoPharm Taiwan Ltd. dated August 22, 2023, containing extensive operational and financial information including half-year financial results, business updates, product pipeline, market analysis, and Q&A. It includes financial tables such as consolidated income statement, balance sheet, and cash flow statement for the first half of 2023, with comparative data from 2022. The content is typical of an interim or quarterly report, providing substantive financial data and analysis for a period shorter than a full fiscal year. It is not a brief announcement, certification, or a simple report publication notice. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-22 Chinese
112年08月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting (法人說明會), including date, time, location, summary of the presentation content, and links to presentation files and video. The content focuses on a scheduled investor presentation event rather than a full report or financial statements. The presence of presentation files and video links confirms this is an Investor Presentation. The document length is short and it is not a report itself but the presentation materials and meeting details. Therefore, the appropriate classification is Investor Presentation (IP).
2023-08-22 Chinese
公告台灣神隆股份有限公司舉行112年上半年線上法人說明會
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of an online investor presentation (法人說明會) for the first half of the year 112 (Taiwan calendar year). It mentions the date, time, and that the presentation will cover financial numbers and operational overview for the first half of the year. It does not contain the actual financial data or detailed report but rather informs about the event where such information will be presented. This fits the definition of an Investor Presentation (IP) announcement. The document length is short and it is clearly an announcement of a presentation, not the presentation itself or a full financial report.
2023-08-15 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.